In a large multi-disciplinary collaboration, researchers from the Viral Hemorrhagic Fever Consortium (VHFC) have published key findings on Lassa virus (LASV) evolution. The study, published in the August 2015 edition of Cell, shares unique insights into the origins and evolutionary dynamics of LASV.
According to an independent field validation study recently published in The Lancet, a new 15 minute rapid Ebola test co-developed by VHFC researchers from Tulane University and Corgenix Medical Corporation is as accurate as much more time consuming traditional lab testing for the disease.
In a large collaboration between Kenema Government Hospital, Harvard University, Broad Institute, Tulane University, Edinburgh University, the Centers for Disease Control, United States Army Medical Research Institute of Infectious Diseases, and others, the Viral Hemorrhagic Fever Consortium has published a paper in Cell detailing the epidemiology, transmission, and evolution of Ebola virus ove
Corgenix, together with Tulane University, Autoimmune Technologies, Zalgen Labs, and other VHFC partners have received approval for their bedside 15-minute ReEBOV Ebola virus test. This will allow patients to be identified and cared for as quickly as possible.
Corgenix Medical Corporation, a VHFC partner, and worldwide developer of diagnostics test kits, has been awarded two grants totaling $818,000 to advance the development of an Ebola rapid diagnostic test kit.
With the ebola epidemic still out of control in West Africa, we applaud Time Magazine’s decision to honor the heroic work of ebola fighters worldwide. This fight is far from over, and it is important that we pay tribute to, recognize and continue to support the selfless work by local healthcare workers, scientists, ministries of health, and aid organizations in Guinea, Liberia, and Sierra Leone.
A feared hallmark of Ebola – uncontrolled bleeding – is a rare symptom in the current outbreak, according to an article in this week’s New England Journal of Medicine that is the largest clinical analysis to date of the West African epidemic.
It is with great sadness that the VHFC mourns the loss of our colleague and friend Dr. Sheik Humarr Khan, Physician In-Charge of the Lassa Fever Program at Kenema Government Hospital in Sierra Leone. Dr. Khan was a leading expert in the clinical care of viral hemorrhagic fevers, devoted to the care of his fellow nationals. Dr.